Clinical trial
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00002430 |
|---|---|
| Title | A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations |
| Official title | A Multicenter, Open-Label, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate/d4T/3TC Versus Indinavir Sulfate/Nelfinavir Mesylate/d4T/3TC in HIV-Infected Individuals |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir sulfate, Nelfinavir mesylate, Lamivudine, Stavudine |
| Enrollment | 220 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: